Lebenthal Global Advisors LLC Sells 100 Shares of Inspire Medical Systems, Inc. (NYSE:INSP)

Lebenthal Global Advisors LLC lessened its stake in shares of Inspire Medical Systems, Inc. (NYSE:INSP) by 3.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,615 shares of the company’s stock after selling 100 shares during the quarter. Lebenthal Global Advisors LLC’s holdings in Inspire Medical Systems were worth $485,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in the stock. State Street Corp grew its stake in shares of Inspire Medical Systems by 78.0% during the 3rd quarter. State Street Corp now owns 1,049,784 shares of the company’s stock valued at $221,557,000 after purchasing an additional 459,990 shares during the period. Point72 Asset Management L.P. increased its holdings in Inspire Medical Systems by 954.4% during the third quarter. Point72 Asset Management L.P. now owns 319,364 shares of the company’s stock valued at $67,402,000 after buying an additional 289,075 shares during the last quarter. Allspring Global Investments Holdings LLC raised its position in Inspire Medical Systems by 798.3% in the third quarter. Allspring Global Investments Holdings LLC now owns 267,852 shares of the company’s stock worth $56,530,000 after acquiring an additional 238,034 shares during the period. Riverbridge Partners LLC bought a new position in Inspire Medical Systems in the fourth quarter worth approximately $26,342,000. Finally, AQR Capital Management LLC boosted its stake in shares of Inspire Medical Systems by 152.7% during the 2nd quarter. AQR Capital Management LLC now owns 231,845 shares of the company’s stock worth $31,028,000 after acquiring an additional 140,090 shares during the last quarter. 94.91% of the stock is currently owned by institutional investors.

Inspire Medical Systems Trading Down 2.1 %

INSP opened at $184.49 on Tuesday. Inspire Medical Systems, Inc. has a 12 month low of $123.00 and a 12 month high of $257.40. The firm has a market cap of $5.53 billion, a price-to-earnings ratio of 172.42 and a beta of 1.32. The stock has a fifty day moving average price of $189.32 and a 200-day moving average price of $187.20.

Inspire Medical Systems (NYSE:INSP) last issued its quarterly earnings results on Monday, November 4th. The company reported $0.60 earnings per share for the quarter, topping analysts’ consensus estimates of $0.06 by $0.54. The business had revenue of $203.20 million for the quarter, compared to analyst estimates of $197.59 million. Inspire Medical Systems had a return on equity of 5.30% and a net margin of 4.37%. The company’s revenue was up 32.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned ($0.29) earnings per share. On average, equities research analysts forecast that Inspire Medical Systems, Inc. will post 1.35 EPS for the current year.

Analysts Set New Price Targets

Several research analysts have recently commented on INSP shares. KeyCorp reaffirmed an “overweight” rating and issued a $234.00 price objective (down previously from $236.00) on shares of Inspire Medical Systems in a research note on Friday. Wells Fargo & Company increased their price target on Inspire Medical Systems from $187.00 to $198.00 and gave the company an “equal weight” rating in a research note on Tuesday, November 5th. Bank of America upgraded shares of Inspire Medical Systems from a “neutral” rating to a “buy” rating and upped their target price for the company from $220.00 to $255.00 in a research report on Wednesday, November 20th. Truist Financial reaffirmed a “buy” rating and set a $240.00 price objective (up from $217.00) on shares of Inspire Medical Systems in a research note on Monday, September 30th. Finally, Robert W. Baird raised their price target on Inspire Medical Systems from $240.00 to $252.00 and gave the stock an “outperform” rating in a research note on Tuesday, November 5th. Three analysts have rated the stock with a hold rating and eight have given a buy rating to the company. Based on data from MarketBeat, Inspire Medical Systems presently has a consensus rating of “Moderate Buy” and a consensus target price of $231.45.

Inspire Medical Systems Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.